about
Recurrent cyclin D2 mutations in myeloid neoplasms.Identification of Interleukin-1 by Functional Screening as a Key Mediator of Cellular Expansion and Disease Progression in Acute Myeloid Leukemia.Targeting of colony-stimulating factor 1 receptor (CSF1R) in the CLL microenvironment yields antineoplastic activity in primary patient samples.FGF2-FGFR1 signaling regulates release of Leukemia-Protective exosomes from bone marrow stromal cellsAutomated decision tree to evaluate genetic abnormalities when determining prognostic risk in acute myeloid leukemiaEstimating the Screening-Eligible Population Size, aged 45 to 74, at Average Risk to Develop Colorectal Cancer in the United StatesColorectal cancer outcomes after screening with the multi-target stool DNA assay: protocol for a large-scale, prospective cohort study (the Voyage study)CSF1R inhibitors exhibit antitumor activity in acute myeloid leukemia by blocking paracrine signals from support cells
P50
Q40153559-D84F89AF-DBF4-42FE-AA8B-FA6DFC46BEC8Q40268513-3DA32327-7696-4CF6-B3EE-1697AFFCCB05Q55015828-2248F073-3F2A-4EE7-B107-DEF4764DA47DQ61799276-3CD8930C-C70A-4C0F-BA80-9A8CB5F7B458Q62516277-D3C2CC3E-2BA9-4846-AD03-E70CAA3A24F1Q89581075-5C436376-3050-48AD-A8DB-2C19D81A4BBEQ90015302-B1D3A44B-C4DD-488B-B3DF-72628B3CF62DQ93051409-467985A4-D230-4D0C-96C3-F3285DA5DFB8
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
David K Edwards
@en
David K Edwards
@nl
type
label
David K Edwards
@en
David K Edwards
@nl
prefLabel
David K Edwards
@en
David K Edwards
@nl
P31
P496
0000-0003-2708-9562